Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Welcome to Fierce Biotech's fifth annual layoff tracker, a resource designed to keep pace with the sector's steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...

The University of Texas at Austin and the Welch Foundation invite you to a distinguished lecture by Dr. Robert S. Langer, Institute Professor at MIT and a leading innovator in biomaterials and ...

EXCLUSIVE: More leaked PowerPoint lectures from a first-year University of Illinois Urbana-Champaign class show left-wing ideology woven into the fabric of the course. Fox News Digital obtained course ...

American biotech company BioMarin Pharmaceutical Inc. has entered into an agreement to acquire Amicus Therapeutics Inc. This is reported in a BioMarin press release. The transaction value is $4.8 ...

Something remarkable is happening in Chinese biotech, and it’s happening fast. The country’s drug developers are learning to run — really run — through clinical trials and regulatory approvals. In an ...

Are you a hedgehog or a fox? Isaiah Berlin's descriptive dichotomy is based on the ancient Greek poet Archilochus' fragment of verse, “The fox knows many things, but the hedgehog knows one big thing” ...

Artist’s impression of a protein translocating through a nanopore. Yu et al. identify conditions that allow complete proteins to translocate through a nanopore when driven by an electroosmotic effect.